EG1
(Pax2 inhibitor EG1) manufacturers
- EG1
-
- $31.00 / 2mg
-
2026-04-13
- CAS:693241-54-2
- Min. Order:
- Purity: 97.73%
- Supply Ability: 10g
|
| | EG1
(Pax2 inhibitor EG1) Basic information |
| Product Name: | EG1
(Pax2 inhibitor EG1) | | Synonyms: | EG1
(Pax2 inhibitor EG1);Benzoic acid, 2-[[4-[(2-methoxybenzoyl)amino]benzoyl]amino]-;Pax2 inhibitor EG1;kidney,Inhibitor,embryonic,EG 1,EG1,inhibit,EG-1,EGFP,proliferation;2-(4-(2-Methoxybenzamido)benzamido)benzoic acid;EG1, 10 mM in DMSO;2-[[4-[(2-Methoxybenzoyl)amino]benzoyl]amino]benzoic acid | | CAS: | 693241-54-2 | | MF: | C22H18N2O5 | | MW: | 390.39 | | EINECS: | | | Product Categories: | | | Mol File: | 693241-54-2.mol |  |
| | EG1
(Pax2 inhibitor EG1) Chemical Properties |
| Boiling point | 490.9±40.0 °C(Predicted) | | density | 1.376±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 83.33 mg/mL (213.45 mM; Need ultrasonic) | | form | Solid | | pka | 3.44±0.36(Predicted) | | color | Off-white to yellow |
| | EG1
(Pax2 inhibitor EG1) Usage And Synthesis |
| Uses | EG1, a specific Pax2 inhibitor, directly binds the paired domain of Pax2 (Kd=1.35-1.5 μM) and inhibits Pax2-DNA interactions. EG1 can inhibit embryonic kidney development, a process directly dependent on Pax2 activity[1]. | | References | [1] Grimley E, et al. Inhibition of Pax2 Transcription Activation with a Small Molecule that Targets the DNA Binding Domain. ACS Chem Biol. 2017;12(3):724-734. DOI:10.1021/acschembio.6b00782 |
| | EG1
(Pax2 inhibitor EG1) Preparation Products And Raw materials |
|